114 related articles for article (PubMed ID: 15370701)
1. Urinary 9alpha,11beta-prostaglandin F(2) in children with atopic eczema/dermatitis syndrome: an indicator of mast cell activation?
Øymar K; Aksnes L
Acta Derm Venereol; 2004; 84(5):359-62. PubMed ID: 15370701
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome.
Øymar K; Aksnes L
Allergy; 2005 Jan; 60(1):86-9. PubMed ID: 15575936
[TBL] [Abstract][Full Text] [Related]
3. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
Misso NL; Aggarwal S; Thompson PJ; Vally H
Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
[TBL] [Abstract][Full Text] [Related]
4. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
[TBL] [Abstract][Full Text] [Related]
5. Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome.
Øymar K; Halvorsen T; Aksnes L
Pediatr Allergy Immunol; 2006 Feb; 17(1):37-42. PubMed ID: 16426253
[TBL] [Abstract][Full Text] [Related]
6. Atopy patch test in the diagnosis of food allergy in children with atopic eczema dermatitis syndrome.
Cudowska B; Kaczmarski M
Rocz Akad Med Bialymst; 2005; 50():261-7. PubMed ID: 16358980
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity to hydrolyzed cow's milk protein formula in infants and young children with atopic eczema/dermatitis syndrome with cow's milk protein allergy.
Kaczmarski M; Wasilewska J; Lasota M
Rocz Akad Med Bialymst; 2005; 50():274-8. PubMed ID: 16358982
[TBL] [Abstract][Full Text] [Related]
8. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.
Bochenek G; Nizankowska E; Gielicz A; Swierczyńska M; Szczeklik A
Thorax; 2004 Jun; 59(6):459-64. PubMed ID: 15170023
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS.
Koda N; Tsutsui Y; Niwa H; Ito S; Woodward DF; Watanabe K
Arch Biochem Biophys; 2004 Apr; 424(2):128-36. PubMed ID: 15047184
[TBL] [Abstract][Full Text] [Related]
10. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
11. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers.
Higashi N; Mita H; Ono E; Fukutomi Y; Yamaguchi H; Kajiwara K; Tanimoto H; Sekiya K; Akiyama K; Taniguchi M
J Allergy Clin Immunol; 2010 May; 125(5):1084-1091.e6. PubMed ID: 20304469
[TBL] [Abstract][Full Text] [Related]
12. Leptin and urinary leukotriene E4 and 9α,11β-prostaglandin F2 release after exercise challenge.
Baek HS; Choi JH; Oh JW; Lee HB
Ann Allergy Asthma Immunol; 2013 Aug; 111(2):112-7. PubMed ID: 23886229
[TBL] [Abstract][Full Text] [Related]
13. Urinary leukotriene E4 correlates with severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Li CY; Chan IH; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):277-81. PubMed ID: 15115511
[TBL] [Abstract][Full Text] [Related]
14. 9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.
Nittner-Marszalska M; Cichocka-Jarosz E; Sanak M; Wujczyk M; Dor-Wojnarowska A; Lis G; Liebhart J
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):317-25. PubMed ID: 25763689
[TBL] [Abstract][Full Text] [Related]
15. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
16. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fecal microflora in children with atopic eczema/dermatitis syndrome according to IgE sensitization to food.
Kendler M; Uter W; Rueffer A; Shimshoni R; Jecht E
Pediatr Allergy Immunol; 2006 Mar; 17(2):141-7. PubMed ID: 16618364
[TBL] [Abstract][Full Text] [Related]
18. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
19. Candida albicans-specific lymphoproliferative and cytokine (IL-4 and IFN-gamma) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+CD56 ratio elevations in vitro.
Kosonen J; Luhtala M; Viander M; Kalimo K; Terho EO; Savolainen J
Exp Dermatol; 2005 Jul; 14(7):551-8. PubMed ID: 15946244
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype.
Leonardi S; Cuppari C; Manti S; Filippelli M; Parisi GF; Borgia F; Briuglia S; Cannavò P; Salpietro A; Arrigo T; Salpietro C
Allergy Asthma Proc; 2015; 36(1):74-81. PubMed ID: 25562560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
